Revolutionizing Cancer Treatment
Published on
Philanthropy helped CHOP develop the first cell therapy to receive FDA approval and provide lifesaving treatments to 170 children with ALL, like Paulina.
Cellular Therapy and Transplant Section News and Updates
31 - 35 of 35
Pediatric Immunotherapy: What’s Next for CAR-T Therapy
Published on
The FDA approval of Kymriah™ has shifted the paradigm for pediatric cancer treatment — and at Children's Hospital of Philadelphia, more cell therapies are on the horizon.
FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia
Published on
This is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this new era of cellular therapies that treat cancer with a patient’s own immune system.
Five Years Later, First Pediatric Recipient of CAR T-Cell Therapy Remains Cancer-free
Published on
Five years after her T-cell therapy for ALL, Emily remains cancer-free. CHOP has since treated more than 170 patients in clinical trials that have seen a 93% remission rate.
Dr. Stephan Grupp to Lead Cellular Therapy and Transplant Section in CHOP Cancer Program
Published on
A leading pediatric oncologist at CHOP, Dr. Grupp is now Chief of the Section of Cellular Therapy and Transplant in the Hospital’s Division of Oncology.
Pages
- « first
- ‹ previous
- 4
- next ›
- last »